KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,544,000 | -20.8% | 667,400 | -1.2% | 0.01% | -18.2% |
| Q2 2016 | $4,473,000 | +41.7% | 675,702 | 0.0% | 0.01% | +57.1% |
| Q1 2016 | $3,156,000 | -7.1% | 675,702 | +0.4% | 0.01% | -12.5% |
| Q4 2015 | $3,399,000 | +43.4% | 673,163 | 0.0% | 0.01% | +60.0% |
| Q3 2015 | $2,370,000 | -26.1% | 673,163 | +109.5% | 0.01% | -16.7% |
| Q2 2015 | $3,207,000 | +63.2% | 321,306 | +108.2% | 0.01% | +50.0% |
| Q1 2015 | $1,965,000 | – | 154,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |